Cargando…
Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
This study tested progesterone for perimenopausal hot flush ± night sweat (vasomotor symptom, VMS) treatment. It was a double-blind, randomized trial of 300 mg oral micronized progesterone@bedtime versus placebo for 3-months (m) after a 1-m untreated baseline during 2012/1–2017/4. We randomized untr...
Autores principales: | Prior, Jerilynn C., Cameron, Andrea, Fung, Michelle, Hitchcock, Christine L., Janssen, Patricia, Lee, Terry, Singer, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241804/ https://www.ncbi.nlm.nih.gov/pubmed/37277418 http://dx.doi.org/10.1038/s41598-023-35826-w |
Ejemplares similares
-
SAT-239 Bioidentical Estradiol and Progesterone Improved Hot Flushes, Night Sweats and Sweating
por: Liu, James, et al.
Publicado: (2019) -
Don’t ignore perimenopause
por: Prior, Jerilynn C., et al.
Publicado: (2023) -
Progesterone for Symptomatic Perimenopause Treatment – Progesterone politics, physiology and potential for perimenopause
por: Prior, J.C.
Publicado: (2011) -
Effectiveness of nurse‐led group CBT for hot flushes and night sweats in women with breast cancer: Results of the MENOS4 randomised controlled trial
por: Fenlon, Deborah, et al.
Publicado: (2020) -
Progesterone Therapy, Endothelial Function and Cardiovascular Risk Factors: A 3-Month Randomized, Placebo-Controlled Trial in Healthy Early Postmenopausal Women
por: Prior, Jerilynn C., et al.
Publicado: (2014)